Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

We'd appreciate your feedback on this new experience.Tell us what you think(opens in new tab/window)

Elsevier
Publish with us
Shopping Cart
User account

Conference speaker

Carl Goodyear

CG

Carl Goodyear

The University of Glasgow, UK

Carl is Assistant Vice Principal (Strategy & Resources) at the University of Glasgow, and Professor of Translational Immunology & Director for Innovation, Engagement & Enterprise in the School of Infection & Immunity. 

His research is currently focused on understanding immunopathogenesis of disease (i.e., Rheumatoid Arthritis, Osteoarthritis & Multiple Myeloma) and translating this knowledge into viable therapeutic agents for patients. He leads a Translational Immunology programme that provides the critical interface between clinical and basic science, with a specific focus on precision medicine. In parallel, he is also the Director of the GLAZgo Discovery Centre and the Glasgow-Lilly Centre, strategic collaborations between the University of Glasgow and AstraZeneca, and Eli-Lilly respectively. Both of which are aimed at driving innovative academic/industry research. Carl has published widely in the areas of immunobiology and rheumatology. He is a Chair/Deputy Chair or member of various Research Advisory committees & grant review Panels.